NO20013301L - Ny dialysemetode - Google Patents
Ny dialysemetodeInfo
- Publication number
- NO20013301L NO20013301L NO20013301A NO20013301A NO20013301L NO 20013301 L NO20013301 L NO 20013301L NO 20013301 A NO20013301 A NO 20013301A NO 20013301 A NO20013301 A NO 20013301A NO 20013301 L NO20013301 L NO 20013301L
- Authority
- NO
- Norway
- Prior art keywords
- dialysis method
- dialysis
- new dialysis
- molecular weight
- low molecular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/342—Adding solutions to the blood, e.g. substitution solutions
- A61M1/3424—Substitution fluid path
- A61M1/3427—Substitution fluid path back through the membrane, e.g. by inverted trans-membrane pressure [TMP]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3672—Means preventing coagulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- External Artificial Organs (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Peptides Or Proteins (AREA)
Abstract
Anvendelse av en trombininhibitor av lav molekylvekt for fremstilling av et legemiddel for behandling ved dialyse, spesielt hemodialyse, av en pasient som har behov for slik behandling, hvor trombininhibitoren tilveiebringes i dialyseoppløsningen, samt dialyse-oppløsninger og konsentrater innbefattende trombininhibitorer av lav molekylvekt, slik som melagatran.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9900043A SE9900043D0 (sv) | 1999-01-11 | 1999-01-11 | New use |
PCT/SE2000/000030 WO2000041715A1 (en) | 1999-01-11 | 2000-01-11 | New dialysis method |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20013301D0 NO20013301D0 (no) | 2001-07-03 |
NO20013301L true NO20013301L (no) | 2001-07-03 |
NO326996B1 NO326996B1 (no) | 2009-03-30 |
Family
ID=20414050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20013301A NO326996B1 (no) | 1999-01-11 | 2001-07-03 | Anvendelse av trombininhibitor for fremstilling av et medikament for dialysebehandling. |
Country Status (19)
Country | Link |
---|---|
US (4) | US20030042202A1 (no) |
EP (1) | EP1144000B1 (no) |
JP (1) | JP4054533B2 (no) |
KR (1) | KR100840452B1 (no) |
CN (1) | CN100387296C (no) |
AT (1) | ATE316384T1 (no) |
AU (1) | AU763185B2 (no) |
BR (1) | BR0007448A (no) |
CA (1) | CA2356440A1 (no) |
CY (1) | CY1107461T1 (no) |
DE (1) | DE60025698T2 (no) |
DK (1) | DK1144000T3 (no) |
ES (1) | ES2255968T3 (no) |
IL (1) | IL143824A0 (no) |
NO (1) | NO326996B1 (no) |
NZ (1) | NZ512712A (no) |
SE (1) | SE9900043D0 (no) |
WO (1) | WO2000041715A1 (no) |
ZA (1) | ZA200105274B (no) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1466916B1 (en) | 2002-09-09 | 2007-10-24 | Trigen Limited | Peptide boronic acids useful in making salts thereof |
US7112572B2 (en) | 2002-09-09 | 2006-09-26 | Trigen Limited | Multivalent metal salts of boronic acids |
US7235589B2 (en) * | 2004-09-21 | 2007-06-26 | Bio Numerik Pharmaceuticals, Inc. | Method of treating patients undergoing kidney dialysis |
CN105115949B (zh) * | 2005-12-21 | 2018-06-22 | 梅索斯卡莱科技公司 | 分析装置、方法和试剂 |
CA3122671A1 (en) | 2005-12-21 | 2008-05-15 | Meso Scale Technologies, Llc. | Assay apparatuses, methods and reagents |
US20070155672A1 (en) * | 2006-01-05 | 2007-07-05 | Markus Voges | Sterilized peritoneal dialysis solutions containing heparin |
ES2647775T3 (es) * | 2011-08-02 | 2017-12-26 | Medtronic, Inc. | Sistema de hemodiálisis que tiene una trayectoria de flujo con un volumen distensible controlado |
US9623164B2 (en) | 2013-02-01 | 2017-04-18 | Medtronic, Inc. | Systems and methods for multifunctional volumetric fluid control |
US10010663B2 (en) | 2013-02-01 | 2018-07-03 | Medtronic, Inc. | Fluid circuit for delivery of renal replacement therapies |
US10850016B2 (en) | 2013-02-01 | 2020-12-01 | Medtronic, Inc. | Modular fluid therapy system having jumpered flow paths and systems and methods for cleaning and disinfection |
US10874787B2 (en) | 2014-12-10 | 2020-12-29 | Medtronic, Inc. | Degassing system for dialysis |
US9713665B2 (en) | 2014-12-10 | 2017-07-25 | Medtronic, Inc. | Degassing system for dialysis |
US10098993B2 (en) | 2014-12-10 | 2018-10-16 | Medtronic, Inc. | Sensing and storage system for fluid balance |
US11278654B2 (en) | 2017-12-07 | 2022-03-22 | Medtronic, Inc. | Pneumatic manifold for a dialysis system |
US11033667B2 (en) | 2018-02-02 | 2021-06-15 | Medtronic, Inc. | Sorbent manifold for a dialysis system |
US11110215B2 (en) | 2018-02-23 | 2021-09-07 | Medtronic, Inc. | Degasser and vent manifolds for dialysis |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU178398B (en) * | 1979-06-12 | 1982-04-28 | Gyogyszerkutato Intezet | Process for producing new agmatine derivatives of activity against haemagglutination |
US4489535A (en) * | 1980-10-02 | 1984-12-25 | Veltman Preston Leonard | Materials and method for preparing dialysis solutions containing bicarbonate ions |
GR870129B (en) * | 1987-01-27 | 1987-02-04 | Giatzidis Ippokratis | Stable bicarbonate - glycylglycine dialysate for hemodialysis and peritoneal dialysis |
SE9103612D0 (sv) * | 1991-12-04 | 1991-12-04 | Astra Ab | New peptide derivatives |
US5549674A (en) * | 1992-03-02 | 1996-08-27 | The Regents Of The University Of Michigan | Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo |
SE9301916D0 (sv) * | 1993-06-03 | 1993-06-03 | Ab Astra | New peptides derivatives |
DE4321444A1 (de) * | 1993-06-28 | 1995-01-05 | Bernd Prof Dr Clement | Pharmazeutische Zubereitung |
US5380299A (en) * | 1993-08-30 | 1995-01-10 | Med Institute, Inc. | Thrombolytic treated intravascular medical device |
US5705487A (en) * | 1994-03-04 | 1998-01-06 | Eli Lilly And Company | Antithrombotic agents |
US5707966A (en) * | 1994-03-04 | 1998-01-13 | Eli Lilly And Company | Antithrombotic agents |
DE4443390A1 (de) * | 1994-12-06 | 1996-06-13 | Basf Ag | Neue dipeptidische p-Amidinobenzylamide mit N-terminalen Sulfonyl- bzw. Aminosulfonylresten |
KR19980702112A (ko) * | 1995-02-10 | 1998-07-15 | 페라 스타르크,요헨 카르크 | 트롬빈 억제제 |
US5710130A (en) * | 1995-02-27 | 1998-01-20 | Eli Lilly And Company | Antithrombotic agents |
SE9600216D0 (sv) * | 1996-01-18 | 1996-01-18 | Hans Arne Hansson | Styrning av läkningsprocesser |
CZ291690B6 (cs) * | 1996-02-13 | 2003-05-14 | Akzo Nobel N. V. | Inhibitory serinové proteázy a farmaceutický prostředek |
EP0884325A1 (en) * | 1997-04-24 | 1998-12-16 | Akzo Nobel N.V. | Thrombin inhibitors containing a peptidyl heterocycle |
CA2288224A1 (en) * | 1997-04-30 | 1998-11-05 | Mary George Johnson | Antithrombotic agents |
AU7270798A (en) * | 1997-05-01 | 1998-11-24 | Eli Lilly And Company | Antithrombotic agents |
WO1998050420A1 (en) * | 1997-05-02 | 1998-11-12 | Akzo Nobel N.V. | Serine protease inhibitors |
-
1999
- 1999-01-11 SE SE9900043A patent/SE9900043D0/xx unknown
-
2000
- 2000-01-11 EP EP00901367A patent/EP1144000B1/en not_active Expired - Lifetime
- 2000-01-11 ES ES00901367T patent/ES2255968T3/es not_active Expired - Lifetime
- 2000-01-11 AU AU21409/00A patent/AU763185B2/en not_active Ceased
- 2000-01-11 KR KR1020017008703A patent/KR100840452B1/ko not_active IP Right Cessation
- 2000-01-11 DE DE60025698T patent/DE60025698T2/de not_active Expired - Lifetime
- 2000-01-11 JP JP2000593325A patent/JP4054533B2/ja not_active Expired - Fee Related
- 2000-01-11 BR BR0007448-9A patent/BR0007448A/pt not_active Application Discontinuation
- 2000-01-11 AT AT00901367T patent/ATE316384T1/de active
- 2000-01-11 NZ NZ512712A patent/NZ512712A/en not_active IP Right Cessation
- 2000-01-11 IL IL14382400A patent/IL143824A0/xx unknown
- 2000-01-11 CA CA002356440A patent/CA2356440A1/en not_active Abandoned
- 2000-01-11 CN CNB008026963A patent/CN100387296C/zh not_active Expired - Fee Related
- 2000-01-11 WO PCT/SE2000/000030 patent/WO2000041715A1/en active IP Right Grant
- 2000-01-11 DK DK00901367T patent/DK1144000T3/da active
-
2001
- 2001-06-26 ZA ZA200105274A patent/ZA200105274B/en unknown
- 2001-07-03 NO NO20013301A patent/NO326996B1/no not_active IP Right Cessation
-
2002
- 2002-03-18 US US10/098,625 patent/US20030042202A1/en not_active Abandoned
-
2005
- 2005-03-09 US US11/074,893 patent/US20050153904A1/en not_active Abandoned
-
2006
- 2006-04-19 CY CY20061100544T patent/CY1107461T1/el unknown
-
2007
- 2007-07-27 US US11/878,881 patent/US20080004225A1/en not_active Abandoned
-
2008
- 2008-08-12 US US12/222,604 patent/US20090192137A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20050153904A1 (en) | 2005-07-14 |
EP1144000A1 (en) | 2001-10-17 |
BR0007448A (pt) | 2001-10-16 |
EP1144000B1 (en) | 2006-01-25 |
CN1354673A (zh) | 2002-06-19 |
AU2140900A (en) | 2000-08-01 |
IL143824A0 (en) | 2002-04-21 |
SE9900043D0 (sv) | 1999-01-11 |
US20090192137A1 (en) | 2009-07-30 |
KR100840452B1 (ko) | 2008-06-20 |
US20030042202A1 (en) | 2003-03-06 |
US20080004225A1 (en) | 2008-01-03 |
JP2002534217A (ja) | 2002-10-15 |
AU763185B2 (en) | 2003-07-17 |
JP4054533B2 (ja) | 2008-02-27 |
NZ512712A (en) | 2004-09-24 |
ES2255968T3 (es) | 2006-07-16 |
NO20013301D0 (no) | 2001-07-03 |
NO326996B1 (no) | 2009-03-30 |
WO2000041715A1 (en) | 2000-07-20 |
ATE316384T1 (de) | 2006-02-15 |
CA2356440A1 (en) | 2000-07-20 |
CY1107461T1 (el) | 2012-12-19 |
DE60025698T2 (de) | 2006-10-19 |
ZA200105274B (en) | 2002-09-26 |
CN100387296C (zh) | 2008-05-14 |
DE60025698D1 (de) | 2006-04-13 |
KR20010093250A (ko) | 2001-10-27 |
DK1144000T3 (da) | 2006-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20013301L (no) | Ny dialysemetode | |
NO972475L (no) | Ny antitrombotisk formulering, fremgangsmåte for dens fremstilling og anvendelse derav | |
DE60039301D1 (de) | Spüllösungen und verfahren zur schmerzhemmung, entzündungshemmung und hemmung des knorpelabbaus | |
NO20060416L (no) | Ny anvendelse I | |
EP1271386A3 (en) | Apparatus and process for assessing medical facilities | |
AR042795A1 (es) | Fluidos de dialisis biocompatibles que contienen icodextrinas | |
SE9702860L (sv) | Användning av en stam av Lactobacillus för tillverkning av ett läkemedel för reduktion av fibrinogenhalten i blod | |
WO2005027993A3 (en) | Vascular access preservation in hemodialysis patients | |
NZ515567A (en) | Method for treating chronic pain using MEK inhibitors | |
WO2004010937A3 (en) | Method of treating cancer | |
ATE337786T1 (de) | Verwendung von taurolidine oder taurultam zur behandlung und prävention von infektionen in medizinischen freisetzungssystemen | |
CY1105068T1 (el) | ΈΝΑ ΠΡΟΪΟΝ ΣΥΝΔΥΑΣΜΟΥ ΠΟΥ ΠEPΙΛΑΜΒΑΝΕΙ ΜΕΛΑΓΑΤΡΑΝΗ ΚΑΙ ΕΝΑΝ ΑΝΑΣΤΟΛΕΑ ΠΑΡΑΓΟΝΤΑ ΓΙΑ Xa | |
DE60039978D1 (de) | Substitutions-infusionflüssigkeit und zitratanticoagulation | |
NO20054459L (no) | Liposompreparat for reduksjon av liposomindusert komplementaktivering | |
NO20020056D0 (no) | Fremgangsmåte og system for anvendelse ved behandling av en pasient med et hvilket som helst medikament for å optimalisereterapien og forhindre en negativ medikamentrespons | |
ATE373725T1 (de) | Methoden zur feststellung von akute myeloischen leukämie | |
PT1196185E (pt) | Nova utilizacao de solucoes salinas hipo-osmoticas e medicamento a base de tais solucoes | |
NO20052313L (no) | Vandig farmasoytisk formulering omfattende trombininhibitorer melagatran og anvendelse av formuleringen for fremstilling av et medikament for anvendelse i nasal administrering i behandling av | |
DE50111407D1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
ATE262362T1 (de) | Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung | |
DE60117762D1 (de) | Vitamin d-verbindungen zur behandlung von chronischer tranplantatnephropathie bei nieren transplantieren patienten | |
GB0007239D0 (en) | Use | |
BR0316059A (pt) | Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise | |
NO985558L (no) | Ny forbedret formulering for behandling av tromboembolisme | |
Shetty et al. | Connecting devices in CAPD and their impact on peritonitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |